Global Fluorescent In Situ Hybridization Probe Market Size Likely to Grow at a CAGR of 7.9% By 2035

The market size of global fluorescent in situ hybridization probes is estimated to reach USD 1.14 billion in 2025 and to grow to between USD 1.23 billion in 2026 and an estimated USD 2.27 billion by 2035 with a CAGR of 7.9% from 2026 through 2035.

Fluorescent in Situ Hybridization Probe Market Revenue and Trends

Fluorescent in situ hybridization (FISH) probes the global market related to fluorescent in situ hybridization (FISH) probes is composed of DNA and RNA probes utilized in detecting and localizing particular genetic sequences in cells and tissues in applications related to cancer diagnostics, genetic disease research, and companion diagnostics.

The market for the global fluorescent in situ hybridization probe is expanding at a high rate due to increased cancer and genetic disorder prevalence, the need for targeted medicine, increased research in the area of genomics and cytogenetics, and the improvement of multiplexed probes, automated imaging, and high-resolution detection technology in healthcare systems across the world.

What are the Factors That Have a Significant Contribution to the Growth of the fluorescent in situ hybridization probe market?

The increase in the cancer rates, genetic mutations, and chromosomal disorders due to the aging populations, the environment, and the enhanced screening has led to the increase in the demand for the FISH probe products. The problem is that, according to multiple reports, millions of people are diagnosed with cancer each year all over the world, and genetic factors significantly contribute to most of the cases.

Growing interest in personalized medicine will see increasing numbers of patients and scientists demand FISH probes to identify biomarkers, choose therapies, and monitor diseases such as leukemia, breast cancer, and rare genetic disorders.

Multiplex FISH probes, AI enhanced analysis, automated platforms and RNA specific probes have been implemented through technological advances, enhancing specificity, throughput, and diagnostic accuracy. Other catalysts are the rising levels of R&D in oncology and genomics, the rising level of adoption of companion diagnostics, increased access to molecular pathology labs, and state funding for cancer research and genetic screening programs in developed and emerging markets.

Segment Insight

By Product Type

The DNA probe market, with the largest presence of products in the fluorescent in situ hybridization probe market as of 2025, is driven by the need of probes to detect chromosomal and gene amplification and deletion in cancer and genetic testing. They play an important role in the early detection, prognostic analysis, and management of oncological and hereditary diseases, and breakthroughs in locus-specific and centromeric DNA probes (often considered by pathologists to be an important part of the reliable cytogenetic analysis and an indicator of targeted therapies) have a key role.

By Distribution Channel

Direct sales by manufacturers and special distributors take the biggest market share and is the main method of distributing custom probe kits, technical assistance, and regulatory-compliant solutions. These channels offer professional validation, training, and integration solutions to the labs with high volume genetic testing, so they are the ones that are favored by the clinical diagnostics laboratory, research laboratories and pathology centers that require the sophisticated FISH assays.

Regional Insights

The market of fluorescent in situ hybridization probes is highly developed in North America because of the well-developed healthcare system, high cancer rates, high attention to precision oncology, and the use of the latest technologies, such as multiplexed FISH probes. The area enjoys strong reimbursement policies, high levels of research investments and the availability of large players in the industry that promotes ongoing research and innovation.

In the meantime, the Asia Pacific region is the most rapidly developing market for fluorescent in situ hybridization probes, due to high patient population, increased burden of cancer and genetic disorders caused by lifestyle changes, swift urbanization, and growing infrastructure of molecular diagnostics. Cultures such as China, India, and Japan are also experiencing the adoption of cost effective FISH probes as their investments are increasing, awareness programs are boosting and government programs on cancer screening and genomics research are underway. The presence of economic growth and digital pathology also drives the markets in Asia Pacific to grow at an even faster rate.

Report Scope

Recent Developments

• In March 2025: Vitro appointed Biocare Medical as the exclusive US distributor for its NeoPATH Pro instrument, a high-throughput automated platform supporting immunohistochemistry (IHC), in situ hybridization (ISH), and fluorescence in situ hybridization (FISH) with a 42-slide capacity for enhanced diagnostic workflows. (Source: Vitro)

List of the prominent players in the Fluorescent In Situ Hybridization Probe Market:

• Thermo Fisher Scientific Inc.

• Abbott Laboratories

• Agilent Technologies Inc.

• F. Hoffmann-La Roche Ltd.

• PerkinElmer Inc.

• Bio-Rad Laboratories Inc.

• Oxford Gene Technology (Sysmex)

• Abnova Corporation

• Empire Genomics LLC

• MetaSystems Group

• Others

The Fluorescent In Situ Hybridization Probe Market is segmented as follows:

By Product Type

• Instruments and Systems

  • Fluorescence Microscopes

  • Automated Imaging Systems

  • Flow Cytometry Systems

• Probes and Kits

  • Locus-Specific Probes

  • Centromeric Probes

  • Whole Chromosome Probes

  • Custom Probes

• Consumables

  • Reagents and Buffers

  • Slides and Coverslips

• Software and Services

By Probe Type

• DNA Probes

• RNA Probes

• PNA Probes (Peptide Nucleic Acid)

By Application

• Cancer Diagnostics

  • Breast Cancer

  • Hematologic Malignancies

  • Solid Tumors

• Genetic Disorder Diagnosis

• Prenatal Testing

• Research Applications

• Other Applications

By End-User

• Hospitals and Diagnostic Laboratories

• Research and Academic Institutes

• Pharmaceutical and Biotechnology Companies

• Contract Research Organizations

Regional Coverage:

North America

• U.S.

• Canada

• Mexico

• Rest of North America 

Europe

• Germany

• France

• U.K.

• Russia

• Italy

• Spain

• Netherlands

• Rest of Europe

Asia Pacific

• China

• Japan

• India

• New Zealand

• Australia

• South Korea

• Taiwan

• Rest of Asia Pacific 

The Middle East & Africa

• Saudi Arabia

• UAE

• Egypt

• Kuwait

• South Africa

• Rest of the Middle East & Africa

Latin America

• Brazil

• Argentina

• Rest of Latin America